应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
PFE 辉瑞
交易中 10-14 11:39:57 EDT
28.99
-0.17
-0.58%
最高
29.17
最低
28.85
成交量
767.58万
今开
29.15
昨收
29.16
日振幅
1.10%
总市值
1,643亿
流通市值
1,641亿
总股本
56.67亿
成交额
2.23亿
换手率
0.14%
流通股本
56.59亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
辉瑞公司治疗血友病的药物Hympavzi成功获批
环球市场播报 · 10-12 02:04
辉瑞公司治疗血友病的药物Hympavzi成功获批
医药行业研究：辉瑞MEVROMETOSTAT在华启动3期临床
太平洋证券股份... · 10-12 00:00
医药行业研究：辉瑞MEVROMETOSTAT在华启动3期临床
辉瑞下跌1.22%，报28.983美元/股
金融界 · 10-11
辉瑞下跌1.22%，报28.983美元/股
辉瑞股价回调，或因一则传闻：该公司威胁前CEO与CFO
智通财经 · 10-11
辉瑞股价回调，或因一则传闻：该公司威胁前CEO与CFO
更新版 2-辉瑞与 Starboard 之争白热化，对冲基金称高管施压
路透中文 · 10-10
更新版 2-辉瑞与 Starboard 之争白热化，对冲基金称高管施压
更新版 1-辉瑞前高管不再支持 Starboard 竞选活动，Starboard 寻求调查
Reuters · 10-10
更新版 1-辉瑞前高管不再支持 Starboard 竞选活动，Starboard 寻求调查
Starboard要求辉瑞成立特别委员会 调查前高管撤回对其支持一事
港股那点事 · 10-10
Starboard要求辉瑞成立特别委员会 调查前高管撤回对其支持一事
Starboard 要求辉瑞董事会成立特别委员会
Reuters · 10-10
Starboard 要求辉瑞董事会成立特别委员会
铁腕投资人携70亿“杀入”辉瑞，全球CEO要“下课”？
E药经理人 · 10-10
铁腕投资人携70亿“杀入”辉瑞，全球CEO要“下课”？
辉瑞(PFE)盘前跌超1% 终止两项治疗呼吸道合胞病毒感染的临床研究
金吾财讯 · 10-10
辉瑞(PFE)盘前跌超1% 终止两项治疗呼吸道合胞病毒感染的临床研究
辉瑞公司的抗癌药物组合在晚期研究中提高了总生存率
Reuters · 10-10
辉瑞公司的抗癌药物组合在晚期研究中提高了总生存率
BUZZ-辉瑞下跌，前高管与激进投资者运动保持距离
Reuters · 10-10
BUZZ-辉瑞下跌，前高管与激进投资者运动保持距离
前辉瑞CEO及CFO表示不会参与激进投资者Starboard Value的行动
格隆汇 · 10-10
前辉瑞CEO及CFO表示不会参与激进投资者Starboard Value的行动
更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动
Reuters · 10-10
更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动
更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动
Reuters · 10-10
更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动
辉瑞前高管未参与 Starboard 针对制药商的竞选活动
Reuters · 10-10
辉瑞前高管未参与 Starboard 针对制药商的竞选活动
辉瑞(PFE.US)癌症新药mevrometostat在华启动3期临床 前期试验中抗癌活性表现良好
智通财经 · 10-10
辉瑞(PFE.US)癌症新药mevrometostat在华启动3期临床 前期试验中抗癌活性表现良好
美股异动 | 辉瑞涨近4%，公司赢得专利诉讼，CEO拟会见激进投资者
老虎资讯综合 · 10-09
美股异动 | 辉瑞涨近4%，公司赢得专利诉讼，CEO拟会见激进投资者
BUZZ-辉瑞上涨；首席执行官布尔拉将会见激进投资者 Starboard，英国《金融时报》报导
Reuters · 10-09
BUZZ-辉瑞上涨；首席执行官布尔拉将会见激进投资者 Starboard，英国《金融时报》报导
辉瑞上涨3.03%，报30.065美元/股
金融界 · 10-09
辉瑞上涨3.03%，报30.065美元/股
加载更多
公司概况
公司名称：
辉瑞
所属市场：
NYSE
上市日期：
--
主营业务：
辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。
发行价格：
--
{"stockData":{"symbol":"PFE","market":"US","secType":"STK","nameCN":"辉瑞","latestPrice":28.992,"timestamp":1728920397324,"preClose":29.16,"halted":0,"volume":7675766,"delay":0,"floatShares":5658685190,"shares":5666695064,"eps":-0.468777,"marketStatus":"交易中","marketStatusCode":2,"change":-0.168,"latestTime":"10-14 11:39:57 EDT","open":29.15,"high":29.17,"low":28.85,"amount":222559971.183368,"amplitude":0.010974,"askPrice":29,"askSize":5935,"bidPrice":28.99,"bidSize":2830,"shortable":3,"etf":0,"ttmEps":-0.468777,"exchange":"NYSE","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1728936000000},"adr":0,"listingDate":-819144000000,"adjPreClose":29.16,"adrRate":0,"dividendRate":0.057257,"preHourTrading":{"tag":"盘前","latestPrice":29.16,"preClose":29.16,"latestTime":"09:29 EDT","volume":73869,"amount":2152542.881607,"timestamp":1728912599015},"postHourTrading":{"tag":"盘后","latestPrice":29.13,"preClose":29.16,"latestTime":"19:59 EDT","volume":1026029,"amount":29917671.3803,"timestamp":1728691195969},"volumeRatio":0.609952,"impliedVol":0.3619,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/PFE","defaultTab":"news","newsList":[{"id":"2474438820","title":"辉瑞公司治疗血友病的药物Hympavzi成功获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2474438820","media":"环球市场播报","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474438820?lang=zh_cn&edition=full","pubTime":"2024-10-12 02:04","pubTimestamp":1728669840,"startTime":"0","endTime":"0","summary":"美国食品和药物管理局批准了辉瑞公司的一款治疗罕见出血性疾病的药物，该药物名为Hympavzi，通过自动注射器笔在皮肤下注射，以预防或减少12岁及以上血友病A或B患者的出血事件。\n Hympavzi是辉瑞公司今年第二个获得美国食品药品监督管理局批准的血友病治疗药物，此前该机构于4月批准了其血友病B基因治疗Beqvez。\n 根据LSEG的估计，分析师预计到2030年，Hympavzi的销售额将达到3亿美元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：陈钰嘉","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/usstock/c/2024-10-12/doc-incsfmip4720595.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-10-12/doc-incsfmip4720595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999002232.USD","LU0225771236.USD","LU0321505439.SGD","LU1066053197.SGD","BK4533","BK4588","LU0868494617.USD","LU1023059063.AUD","LU0985481810.HKD","IE00BLSP4452.SGD","LU0170899867.USD","LU0306806265.USD","LU0306807586.USD","BK4592","LU0058720904.USD","LU0225284248.USD","IE00BBT3K403.USD","BK4007","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU1894683264.USD","SG9999001176.SGD","LU0321505868.SGD","LU1057294990.SGD","SG9999001176.USD","LU0234572021.USD","SG9999013999.USD","BK4585","IE00BLSP4239.USD","SG9999002224.SGD","LU0122379950.USD","LU0289739699.SGD","LU0456855351.SGD","LU1894683348.USD","LU1883839398.USD","BK4550","SG9999003800.SGD","LU1066051498.USD","BK4568","BK4581","BK4534","IE0002270589.USD","PFE"],"gpt_icon":0},{"id":"2474027944","title":"医药行业研究：辉瑞MEVROMETOSTAT在华启动3期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2474027944","media":"太平洋证券股份...","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474027944?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:00","pubTimestamp":1728662400,"startTime":"0","endTime":"0","summary":"行业要闻：近日，CDE 官网公示，辉瑞已启动一项国际多中心（含中国）3 期临床研究，该研究旨在评价PF-06821497 联合恩扎卢胺对比恩扎卢胺或多西他赛对既往接受过醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌患者的疗效和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120807449f3b647b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120807449f3b647b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0234572021.USD","LU1883839398.USD","IE0002270589.USD","LU1894683348.USD","LU0985481810.HKD","LU0058720904.USD","BK4568","IE00BBT3K403.USD","LU1057294990.SGD","SG9999001176.SGD","SGXZ57979304.SGD","BK4588","BK4585","IE000M9KFDE8.USD","PFE","LU0321505868.SGD","LU0456855351.SGD","LU0225284248.USD","LU0289739699.SGD","SG9999002224.SGD","LU0225771236.USD","LU1066051498.USD","SG9999011175.SGD","LU1066053197.SGD","LU1894683264.USD","IE00BLSP4452.SGD","LU0868494617.USD","BK4534","IE00B19Z3581.USD","LU0321505439.SGD","LU0170899867.USD","BK4533","SG9999003800.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","BK4581","SG9999013999.USD","SG9999002232.USD","BK4007","LU0306807586.USD","BK4592","SG9999001176.USD","BK4550","LU1023059063.AUD","LU0122379950.USD","LU0306806265.USD"],"gpt_icon":1},{"id":"2474092024","title":"辉瑞下跌1.22%，报28.983美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474092024","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474092024?lang=zh_cn&edition=full","pubTime":"2024-10-11 21:57","pubTimestamp":1728655037,"startTime":"0","endTime":"0","summary":"10月11日，辉瑞(PFE)盘中下跌1.22%，截至21:57，报28.983美元/股，成交1.23亿美元。财务数据显示，截至2024年06月30日，辉瑞收入总额281.62亿美元，同比减少10.57%；归母净利润31.56亿美元，同比减少59.9%。大事提醒：10月29日，辉瑞将于(美东)盘前披露2024财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/10/11215743933702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0456855351.SGD","LU0289739699.SGD","PFE","LU0170899867.USD","BK4592","LU0306806265.USD","LU0058720904.USD","LU1057294990.SGD","BK4550","LU0225284248.USD","LU0868494617.USD","LU0306807586.USD","LU0321505439.SGD","LU1894683348.USD","SG9999002232.USD","SGXZ57979304.SGD","BK4588","LU0321505868.SGD","IE00B19Z3581.USD","LU1066053197.SGD","BK4007","LU1023059063.AUD","BK4534","BK4581","BK4585","IE00BBT3K403.USD","BK4533","SG9999011175.SGD","SG9999001176.USD","IE00BLSP4239.USD","IE0002270589.USD","LU0985481810.HKD","IE00BLSP4452.SGD","LU1066051498.USD","LU1883839398.USD","LU0234572021.USD","LU0225771236.USD","SG9999002224.SGD","SG9999013999.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU0122379950.USD","IE000M9KFDE8.USD","SG9999003800.SGD","BK4568","LU1894683264.USD"],"gpt_icon":0},{"id":"2474033767","title":"辉瑞股价回调，或因一则传闻：该公司威胁前CEO与CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2474033767","media":"智通财经","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474033767?lang=zh_cn&edition=full","pubTime":"2024-10-11 13:15","pubTimestamp":1728623759,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国知名维权投资机构Starboard Value指控美国制药巨头辉瑞威胁要起诉该公司前任首席执行官以及前首席财务官，以迫使他们与一些激进投资者们在关于该制药巨头的新一轮扭亏为盈运动中分道扬镳。史密斯要求辉瑞董事会组建一个特别委员会来调查此事，称辉瑞高层的一些威胁性质的举措“非常不恰当，公然违反道德规范，严重违反受托与诚信义务”。","market":"hk","thumbnail":"https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f2bb9162f10407908b68d91c8d440880"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2a833fd656eb8ccbb4b0bd30aa329f26","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1192744.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0868494617.USD","BK4588","BK4568","LU0225284248.USD","LU0306807586.USD","SG9999001176.SGD","LU0321505868.SGD","LU1894683348.USD","SG9999002224.SGD","IE00BBT3K403.USD","LU1023059063.AUD","LU0289739699.SGD","LU0985481810.HKD","LU0456855351.SGD","LU1066053197.SGD","BK4534","LU1883839398.USD","LU0170899867.USD","SG9999003800.SGD","BK4007","LU0225771236.USD","LU1894683264.USD","BK4592","LU1057294990.SGD","IE00BLSP4452.SGD","BK4585","LU0122379950.USD","PFE","LU0321505439.SGD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4550","LU0058720904.USD","LU0306806265.USD","LU0234572021.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","SG9999001176.USD","LU1066051498.USD","IE00B19Z3581.USD","SG9999011175.SGD","IE0002270589.USD","SG9999002232.USD","SG9999013999.USD","BK4581","BK4533"],"gpt_icon":1},{"id":"2474726399","title":"更新版 2-辉瑞与 Starboard 之争白热化，对冲基金称高管施压","url":"https://stock-news.laohu8.com/highlight/detail?id=2474726399","media":"路透中文","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474726399?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:18","pubTimestamp":1728566286,"startTime":"0","endTime":"0","summary":"更新版 2-辉瑞与 Starboard 之争白热化，对冲基金称高管施压新版通篇介绍竞选活动、信件、会议、股价和辉瑞历史的细节Svea Herbst-Bayliss/Michael Erman. 路透10月10日 - 周四，辉瑞PFE.N与Starboard Value之间的企业冲突升温，在两名前高管退出针对辉瑞的竞选活动后，这家激进投资公司要求这家美国制药商调查其董事会的行为。Starboard 声称，前高管之所以反悔，是因为辉瑞内部人员或其代表联系了雷德和达梅利奥，\"据称威胁要对他们提起代价高昂的诉讼\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241010:nL4T3LM126:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0122379950.USD","BK4592","IE00BFTCPJ56.SGD","LU0306807586.USD","LU1430594728.SGD","IE00B2B36J28.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0225284248.USD","IE00BLSP4452.SGD","BK4532","SG9999002232.USD","SG9999001176.SGD","BMY","SG9999003800.SGD","LU2360032135.SGD","IE0002270589.USD","SG9999013999.USD","LU0321505439.SGD","LU1894683348.USD","SG9999011175.SGD","IE00BJJMRZ35.SGD","LU1718418525.SGD","SG9999002224.SGD","LU2125154935.USD","LU0170899867.USD","BK4568","LU0237698245.USD","LU2242652126.USD","IE00BLSP4239.USD","LU0234572021.USD","LU1989771016.USD","LU1670710661.SGD","BK4581","IE000M9KFDE8.USD","IE0002141913.USD","LU0058720904.USD","PFE","LU1894683264.USD","LU1066051498.USD","LU0321505868.SGD","BK4533","LU1670711123.USD","LU1670710588.SGD","LU2125154778.USD","SGXZ57979304.SGD","SG9999001176.USD","LU0289739699.SGD","LU1032466523.USD"],"gpt_icon":1},{"id":"2474387745","title":"更新版 1-辉瑞前高管不再支持 Starboard 竞选活动，Starboard 寻求调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2474387745","media":"Reuters","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474387745?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:18","pubTimestamp":1728566286,"startTime":"0","endTime":"0","summary":" 路透10月10日 - 对冲基金Starboard Value周四表示，Starboard Value已要求辉瑞 成立一个 特别委员会，调查关于辉瑞两名前高管 被迫公开宣布支持首席执行官 阿尔伯特-伯拉的指控。该对冲基金称，它了解到 \"辉瑞内部人士 \"已与这两位高管取得联系，并威胁要对他们提起诉讼，除非他们发表支持布尔拉的声明。辉瑞公司没有立即回应置评请求。Starboard 表示，它计划于 10 月 16 日与 Bourla 以及可能的其他董事会成员会面，\"讨论辉瑞的最佳发展道路\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1883839398.USD","IE0002270589.USD","LU0868494617.USD","LU1066053197.SGD","LU1894683264.USD","BK4533","LU0321505868.SGD","LU1023059063.AUD","LU0321505439.SGD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0234572021.USD","SG9999001176.SGD","SG9999002232.USD","SG9999003800.SGD","IE00BLSP4239.USD","SG9999011175.SGD","BK4592","LU1894683348.USD","BK4588","LU0456855351.SGD","BK4550","LU1066051498.USD","IE00B19Z3581.USD","LU0122379950.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0306807586.USD","BABA","SG9999001176.USD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU0058720904.USD","BK4534","LU0306806265.USD","PFE","BK4568","SG9999002224.SGD","LU0225284248.USD","BK4007","LU1057294990.SGD","LU0985481810.HKD","BK4581","LU0170899867.USD"],"gpt_icon":1},{"id":"2474745899","title":"Starboard要求辉瑞成立特别委员会 调查前高管撤回对其支持一事","url":"https://stock-news.laohu8.com/highlight/detail?id=2474745899","media":"港股那点事","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474745899?lang=zh_cn&edition=full","pubTime":"2024-10-10 21:10","pubTimestamp":1728565800,"startTime":"0","endTime":"0","summary":"格隆汇10月10日｜激进投资者Starboard Value LP周四表示，它已要求辉瑞立即成立一个由董事会成员组成的特别委员会，对一些前高管被迫撤回对该投资者的支持一事进行调查。此前，前辉瑞首席执行官Ian Read和前首席财务官Frank D'Amelio在一份声明中表示，他们不会参与Starboard Value的行动。 \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-10-10/doc-incsarns5127439.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-10-10/doc-incsarns5127439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B19Z3B42.SGD","IE00BLSP4239.USD","IE000M9KFDE8.USD","BK4550","BK4588","LU0306807586.USD","SG9999003800.SGD","SG9999002232.USD","LU1894683348.USD","LU1023059063.AUD","LU0321505868.SGD","BK4581","LU0058720904.USD","BK4007","BK4534","IE0002270589.USD","LU1894683264.USD","LU0289739699.SGD","LU0225284248.USD","LU0170899867.USD","SG9999002224.SGD","SG9999001176.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU0234572021.USD","SG9999013999.USD","LU1883839398.USD","LU0306806265.USD","AMZN","BK4585","LU0868494617.USD","LU1066053197.SGD","SG9999011175.SGD","LU0321505439.SGD","BK4568","LU1066051498.USD","IE00B19Z3581.USD","LU0985481810.HKD","LU0456855351.SGD","BK4533","LU0225771236.USD","IE00BLSP4452.SGD","LU1057294990.SGD","LU0122379950.USD","PFE","BK4592","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2474485157","title":"Starboard 要求辉瑞董事会成立特别委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=2474485157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474485157?lang=zh_cn&edition=full","pubTime":"2024-10-10 20:51","pubTimestamp":1728564689,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) 路透10月10日 - Starboard Value LP周四表示，它已要求辉瑞 立即成立一个由董事会成员组成的特别委员会，对一些前高管被迫撤回对该投资者的支持的指控进行调查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU1023059063.AUD","IE00BBT3K403.USD","LU1057294990.SGD","LU1883839398.USD","LU0321505439.SGD","BK4585","LU1066053197.SGD","BK4592","LU0225284248.USD","LU0985481810.HKD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4550","LU0225771236.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4568","BK4533","LU0234572021.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0321505868.SGD","BK4007","LU0170899867.USD","LU0289739699.SGD","BK4581","LU0306806265.USD","BK4534","LU0306807586.USD","SG9999003800.SGD","BK4588","IE00BLSP4452.SGD","SG9999001176.USD","SG9999011175.SGD","LU0456855351.SGD","IE00BLSP4239.USD","LU0058720904.USD","SG9999002232.USD","SG9999013999.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2474748911","title":"铁腕投资人携70亿“杀入”辉瑞，全球CEO要“下课”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2474748911","media":"E药经理人","labels":["Executive Changes","Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474748911?lang=zh_cn&edition=full","pubTime":"2024-10-10 20:28","pubTimestamp":1728563324,"startTime":"0","endTime":"0","summary":"别看10亿美元的入股并不算多，但却足以让辉瑞现任CEO亲自出马。顿时，辉瑞的股价应声上涨。“铁腕”投资人进入，辉瑞转折点来了？投资银行Lazard 在不久前发布的一份报告显示，自2023年以来，全球新发起了几百项激进投资行动，这创下了历史新高。而底层问题恰恰在于，尽管辉瑞在进行适应和调整，但其骨子里关于寻找重磅炸弹的 “顽疾”，目前并未得到根本消除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010204348959d8d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010204348959d8d14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Executive Changes,Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4592","IE0002270589.USD","LU0058720904.USD","LU1894683348.USD","BK4534","BK4568","BK4588","LU0289739699.SGD","LU0234572021.USD","LU0868494617.USD","LU0306807586.USD","LU0122379950.USD","BK4533","SG9999001176.USD","BK4550","IE00BLSP4239.USD","LU0321505439.SGD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BK4007","SG9999001176.SGD","SG9999002232.USD","BK4581","IE00B19Z3B42.SGD","LU0225771236.USD","LU0306806265.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0170899867.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","SG9999013999.USD","SG9999003800.SGD","LU1066051498.USD","PFE","IE000M9KFDE8.USD","LU1066053197.SGD","LU1057294990.SGD","SG9999002224.SGD","LU1894683264.USD","BK4585","LU0985481810.HKD","LU0225284248.USD","LU0321505868.SGD"],"gpt_icon":1},{"id":"2474146287","title":"辉瑞(PFE)盘前跌超1% 终止两项治疗呼吸道合胞病毒感染的临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2474146287","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474146287?lang=zh_cn&edition=full","pubTime":"2024-10-10 19:35","pubTimestamp":1728560106,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞(PFE)盘前跌超1%，截至发稿，报29.8美元。消息面上，辉瑞已终止两项Sisunatovir治疗呼吸道合胞病毒(RSV)感染的临床研究。Sisunatovir是一种口服RSV融合蛋白抑制剂，旨在阻止RSV病毒与宿主细胞的融合。辉瑞发言人表示：“Sisunatovir的临床开发面临持续的挑战，包括与抗酸药的药物相互作用。虽然辉瑞一直在努力解决这些挑战，但最终决定终止Sisunatovir的开发，以集中精力发现和推进其他在研疗法的开发，这些疗法最有可能预防和治疗RSV疾病和其他呼吸道病毒感染。”","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzE4MDg0MTAxNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"280774","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","BK4568","IE0002270589.USD","LU0868494617.USD","SG9999002224.SGD","BK4585","IE00B19Z3B42.SGD","LU0306807586.USD","SG9999001176.USD","LU0122379950.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU0306806265.USD","LU0321505868.SGD","PFE","BK4534","LU0289739699.SGD","BK4533","LU1057294990.SGD","LU0170899867.USD","LU0234572021.USD","BK4592","LU0058720904.USD","LU1894683348.USD","BK4007","SG9999003800.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","SG9999002232.USD","IE00B19Z3581.USD","SG9999011175.SGD","LU0456855351.SGD","IE00BLSP4239.USD","BK4588","LU0321505439.SGD","LU1066051498.USD","BK4550","IE00BBT3K403.USD","LU1066053197.SGD","LU0985481810.HKD","LU1883839398.USD","SGXZ57979304.SGD","LU0225284248.USD","BK4581","SG9999013999.USD","LU0225771236.USD"],"gpt_icon":0},{"id":"2474492713","title":"辉瑞公司的抗癌药物组合在晚期研究中提高了总生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2474492713","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474492713?lang=zh_cn&edition=full","pubTime":"2024-10-10 18:45","pubTimestamp":1728557104,"startTime":"0","endTime":"0","summary":" 路透10月10日 - 辉瑞 周四称，在一项晚期研究中，其药物Talzenna和Xtandi的组合有助于延长一种晚期前列腺癌患者的生命。辉瑞公司说，与Xtandi单药相比，这种联合用药在转移性抗性前列腺癌 患者的总生存期方面有明显改善，无论是否存在基因突变。据辉瑞公司称，约有10%-20%的前列腺癌患者会在确诊后5到7年内患上mCRPC。辉瑞表示，它计划与全球卫生机构分享研究结果，以便更新Talzenna的标签。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"辉瑞公司的抗癌药物组合在晚期研究中提高了总生存率","news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","BK4568","IE0002270589.USD","LU0868494617.USD","SG9999002224.SGD","BK4585","IE00B19Z3B42.SGD","LU0306807586.USD","SG9999001176.USD","LU0122379950.USD","IE00BLSP4452.SGD","LU1023059063.AUD","LU0306806265.USD","LU0321505868.SGD","PFE","BK4534","LU0289739699.SGD","BK4533","LU1057294990.SGD","LU0170899867.USD","LU0234572021.USD","BK4592","LU0058720904.USD","LU1894683348.USD","BK4007","SG9999003800.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","SG9999002232.USD","IE00B19Z3581.USD","SG9999011175.SGD","LU0456855351.SGD","IE00BLSP4239.USD","BK4588","LU0321505439.SGD","LU1066051498.USD","BK4550","IE00BBT3K403.USD","LU1066053197.SGD","LU0985481810.HKD","LU1883839398.USD","SGXZ57979304.SGD","LU0225284248.USD","BK4581","SG9999013999.USD","LU0225771236.USD"],"gpt_icon":1},{"id":"2474797770","title":"BUZZ-辉瑞下跌，前高管与激进投资者运动保持距离","url":"https://stock-news.laohu8.com/highlight/detail?id=2474797770","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474797770?lang=zh_cn&edition=full","pubTime":"2024-10-10 18:05","pubTimestamp":1728554707,"startTime":"0","endTime":"0","summary":" 10月10日 - ** 辉瑞 股价盘前下跌1.6%至29.72美元，昨日盘中上涨约3.5%。** 据知情人士透露，这两位高管早些时候曾表示有兴趣帮助激进投资者** 10 月 6 日，Starboard Value 收购了 大约 10 亿美元的 PFE 股份。** 投资者的目标是进行改革以扭转 PFE 的业绩，因为该公司正努力应对其 COVID 疫苗销售额下降的问题。** 25 家券商中有 11 家将 PFE 评为 \"买入 \"或更高评级，14 家评为 \"持有\"；他们的预测中值为 32.50 美元。** 截至上次收盘，该股今年累计上涨约 5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4533","LU0289739699.SGD","LU1894683264.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0321505439.SGD","LU0306807586.USD","LU0225284248.USD","IE00B19Z3581.USD","LU0456855351.SGD","BK4585","LU1066051498.USD","LU0985481810.HKD","LU1894683348.USD","BK4568","IE00B19Z3B42.SGD","LU0321505868.SGD","LU0306806265.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1057294990.SGD","BK4581","IE00BLSP4452.SGD","PFE","LU1883839398.USD","BK4007","IE0002270589.USD","LU0225771236.USD","LU0868494617.USD","BK4550","SG9999011175.SGD","BK4588","SG9999002232.USD","LU0234572021.USD","SG9999001176.USD","SG9999003800.SGD","SGXZ57979304.SGD","SG9999013999.USD","SG9999001176.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4592","LU0058720904.USD","LU0170899867.USD","LU0122379950.USD"],"gpt_icon":0},{"id":"2474769171","title":"前辉瑞CEO及CFO表示不会参与激进投资者Starboard Value的行动","url":"https://stock-news.laohu8.com/highlight/detail?id=2474769171","media":"格隆汇","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474769171?lang=zh_cn&edition=full","pubTime":"2024-10-10 14:41","pubTimestamp":1728542514,"startTime":"0","endTime":"0","summary":"格隆汇10月10日｜据路透，前辉瑞首席执行官Ian Read和前首席财务官Frank D'Amelio表示，他们不会参与激进投资者Starboard Value的行动。据悉，激进投资者Starboard Value收购约10亿美元辉瑞股份，正推动该公司进行改革。据英国《金融时报》，辉瑞首席执行官Bourla和首席独立董事Shantanu Narayen将于下周与Starboard首席执行官Jeff Smith和负责其医疗保健投资的Patrick Sullivan举行会谈。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410101442009f36822e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410101442009f36822e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002224.SGD","IE00BBT3K403.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU0170899867.USD","SG9999001176.SGD","LU1023059063.AUD","SG9999002232.USD","LU0306806265.USD","SG9999011175.SGD","BK4588","LU0289739699.SGD","LU0122379950.USD","BK4581","LU0868494617.USD","SG9999001176.USD","LU0321505439.SGD","BK4568","LU1894683264.USD","LU1066051498.USD","SGXZ57979304.SGD","BK4550","LU0306807586.USD","LU1894683348.USD","BK4534","LU1066053197.SGD","BK4592","SG9999003800.SGD","BK4533","IE00BLSP4452.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0234572021.USD","LU1057294990.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0225284248.USD","SG9999013999.USD","LU0456855351.SGD","PFE","BK4585","BK4007","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2474968755","title":"更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2474968755","media":"Reuters","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474968755?lang=zh_cn&edition=full","pubTime":"2024-10-10 11:24","pubTimestamp":1728530688,"startTime":"0","endTime":"0","summary":" 路透10月10日 - 辉瑞 前首席执行官伊恩-雷德和前首席财务官弗兰克-达梅利奥表示，他们不会参与激进投资者Starboard Value的投资。\"辉瑞公司的顾问古根海姆合伙公司周三发表声明说：\"我们决定不参与 Starboard Value 有关辉瑞公司的行动。辉瑞和 Starboard 没有立即回应路透的置评请求。自 2020 年以来，辉瑞已斥资 约700 亿美元进行收购，包括去年斥资 430 亿美元收购 Seagen，同时还推出了节约成本的举措。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","SG9999001176.SGD","BK4581","IE00BLSP4239.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4533","SG9999001176.USD","LU1066051498.USD","SG9999011175.SGD","BK4568","BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","LU0456855351.SGD","IE00BLSP4452.SGD","LU1894683348.USD","BK4585","LU0289739699.SGD","LU1883839398.USD","PFE","LU0225771236.USD","SG9999002224.SGD","SG9999003800.SGD","BK4534","LU1066053197.SGD","LU1894683264.USD","LU0306806265.USD","BK4592","IE000M9KFDE8.USD","SG9999002232.USD","LU1057294990.SGD","IE0002270589.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1023059063.AUD","LU0868494617.USD","SG9999013999.USD","LU0058720904.USD","LU0170899867.USD","LU0306807586.USD","BK4007","LU0234572021.USD","BK4550","LU0985481810.HKD","LU0321505868.SGD"],"gpt_icon":1},{"id":"2474775595","title":"更新版 1-辉瑞前首席执行官和首席财务官表示不会参与 Starboard 针对制药商的竞选活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2474775595","media":"Reuters","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474775595?lang=zh_cn&edition=full","pubTime":"2024-10-10 11:24","pubTimestamp":1728530688,"startTime":"0","endTime":"0","summary":" 路透10月10日 - 辉瑞 前首席执行官伊恩-雷德和前首席财务官弗兰克-达梅利奥表示，他们不会参与激进投资者Starboard Value的投资。\"辉瑞公司的顾问古根海姆合伙公司周三发表声明说：\"我们决定不参与 Starboard Value 有关辉瑞公司的行动。辉瑞和 Starboard 没有立即回应路透的置评请求。自 2020 年以来，辉瑞已斥资 约700 亿美元进行收购，包括去年斥资 430 亿美元收购 Seagen，同时还推出了节约成本的举措。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","SG9999001176.SGD","SGXZ57979304.SGD","LU1023059063.AUD","IE00BBT3K403.USD","LU1057294990.SGD","LU1883839398.USD","LU0321505439.SGD","BK4585","LU1066053197.SGD","BK4592","LU0225284248.USD","LU0985481810.HKD","LU1894683264.USD","PFE","SG9999002224.SGD","BK4550","LU0225771236.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0122379950.USD","IE00B19Z3581.USD","BK4568","BK4533","LU0234572021.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0321505868.SGD","BK4007","LU0170899867.USD","LU0289739699.SGD","BK4581","LU0306806265.USD","BK4534","LU0306807586.USD","SG9999003800.SGD","BK4588","IE00BLSP4452.SGD","SG9999001176.USD","SG9999011175.SGD","LU0456855351.SGD","IE00BLSP4239.USD","LU0058720904.USD","SG9999002232.USD","SG9999013999.USD","LU0868494617.USD"],"gpt_icon":1},{"id":"2474730628","title":"辉瑞前高管未参与 Starboard 针对制药商的竞选活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2474730628","media":"Reuters","labels":["Executive Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474730628?lang=zh_cn&edition=full","pubTime":"2024-10-10 10:44","pubTimestamp":1728528255,"startTime":"0","endTime":"0","summary":" 路透10月10日 - 辉瑞 前首席执行官兼董事长伊恩-里德和前首席财务官弗兰克-达梅利奥在一份声明中表示， 他们不会参与激进投资者Starboard Value的投资，Starboard Value希望这家美国制药巨头做出改变以扭转业绩。辉瑞和 Starboard 没有立即回应路透的置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Executive Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1883839398.USD","IE0002270589.USD","LU0868494617.USD","LU1066053197.SGD","LU1894683264.USD","BK4533","LU0321505868.SGD","LU1023059063.AUD","LU0321505439.SGD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0234572021.USD","SG9999001176.SGD","SG9999002232.USD","SG9999003800.SGD","IE00BLSP4239.USD","SG9999011175.SGD","BK4592","LU1894683348.USD","BK4588","LU0456855351.SGD","BK4550","LU1066051498.USD","IE00B19Z3581.USD","LU0122379950.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0306807586.USD","SG9999001176.USD","LU0225771236.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU0058720904.USD","BK4534","LU0306806265.USD","PFE","BK4568","SG9999002224.SGD","LU0225284248.USD","BK4007","LU1057294990.SGD","LU0985481810.HKD","BK4581","LU0170899867.USD"],"gpt_icon":1},{"id":"2474773013","title":"辉瑞(PFE.US)癌症新药mevrometostat在华启动3期临床 前期试验中抗癌活性表现良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2474773013","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474773013?lang=zh_cn&edition=full","pubTime":"2024-10-10 10:25","pubTimestamp":1728527109,"startTime":"0","endTime":"0","summary":"公开资料显示，PF-06821497是一款在研的EZH2抑制剂。根据辉瑞在今年3月在肿瘤学创新日上披露的临床数据，mevrometostat与恩扎卢胺联合疗法在针对经治转移性去势抵抗性前列腺癌患者的1期临床试验中表现出可喜的抗癌活性。同时，这也是本次辉瑞在中国启动的临床研究。例如，他泽司他已获批用于治疗一些类型的血液肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1192158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4592","BK4550","IE00BBT3K403.USD","LU1894683264.USD","LU0289739699.SGD","SG9999003800.SGD","IE0002270589.USD","LU0306807586.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0321505439.SGD","SG9999013999.USD","LU1894683348.USD","BK4581","BK4533","IE000M9KFDE8.USD","LU1023059063.AUD","BK4568","LU0868494617.USD","LU1066053197.SGD","LU0456855351.SGD","LU0122379950.USD","LU1883839398.USD","PFE","BK4007","LU1057294990.SGD","BK4585","LU1066051498.USD","LU0985481810.HKD","IE00BLSP4452.SGD","BK4534","SG9999001176.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","BK4588","LU0321505868.SGD","SGXZ57979304.SGD","SG9999002224.SGD","SG9999002232.USD","LU0225284248.USD","SG9999001176.USD","LU0306806265.USD","SG9999011175.SGD","LU0225771236.USD","LU0170899867.USD","LU0234572021.USD"],"gpt_icon":1},{"id":"1158622701","title":"美股异动 | 辉瑞涨近4%，公司赢得专利诉讼，CEO拟会见激进投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=1158622701","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158622701?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:47","pubTimestamp":1728485243,"startTime":"0","endTime":"0","summary":"本周三（10月9日），医药巨头 $辉瑞(PFE)$ 涨近4%，截至发稿报30.22美元，涨幅3.56%：消息面上，知情人士称，辉瑞CEO艾伯乐计划下周会见激进投资者StarboardValue的主要高管。据悉，StarboardValue已持有辉瑞约10亿美元的股份，并希望这家美国制药巨头做出改变以扭转业绩。此外，辉瑞及其德国合作伙伴BioNTech于周二在伦敦高等法院赢得了使竞争对手CureVac的两项专利无效的诉讼。该技术是辉瑞和BioNTech的COVID-19疫苗的基础。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"美股异动 | 辉瑞涨近4%，公司赢得专利诉讼，CEO拟会见激进投资者","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE"],"gpt_icon":0},{"id":"2474224649","title":"BUZZ-辉瑞上涨；首席执行官布尔拉将会见激进投资者 Starboard，英国《金融时报》报导","url":"https://stock-news.laohu8.com/highlight/detail?id=2474224649","media":"Reuters","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474224649?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:43","pubTimestamp":1728485009,"startTime":"0","endTime":"0","summary":" 10月9日 - ** 辉瑞 早盘股价上涨2.9%至30.04美元** 英国《金融时报》周二晚些时候援引知情人士的话报导称，辉瑞公司首席执行官Albert Bourla计划下周会见激进对冲基金Starboard Value的主要高管 。** 报导称，Bourla和PFE首席独立董事兼Adobe Systems CEO Shantanu Narayen将与Starboard首席执行官Jeff Smith和负责医疗保健投资的Patrick Sullivan举行会谈。** 路透周日援引消息人士的话报导称，Starboard Value 公司已入股 PFE 公司约 10 亿美元，并希望该公司做出改变，扭转业绩。** 年初至今，股价上涨 3.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU1883839398.USD","IE0002270589.USD","LU1894683348.USD","LU0985481810.HKD","LU0058720904.USD","BK4568","IE00BBT3K403.USD","LU1057294990.SGD","SG9999001176.SGD","SGXZ57979304.SGD","BK4588","BK4585","IE000M9KFDE8.USD","PFE","LU0321505868.SGD","LU0456855351.SGD","LU0225284248.USD","LU0289739699.SGD","SG9999002224.SGD","LU0225771236.USD","LU1066051498.USD","SG9999011175.SGD","LU1066053197.SGD","LU1894683264.USD","IE00BLSP4452.SGD","LU0868494617.USD","BK4534","IE00B19Z3581.USD","LU0321505439.SGD","LU0170899867.USD","BK4533","SG9999003800.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","BK4581","SG9999013999.USD","SG9999002232.USD","BK4007","LU0306807586.USD","BK4592","SG9999001176.USD","BK4550","LU1023059063.AUD","LU0122379950.USD","LU0306806265.USD"],"gpt_icon":0},{"id":"2474224409","title":"辉瑞上涨3.03%，报30.065美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474224409","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474224409?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:33","pubTimestamp":1728484434,"startTime":"0","endTime":"0","summary":"10月9日，辉瑞(PFE)盘中上涨3.03%，截至22:33，报30.065美元/股，成交3.72亿美元。财务数据显示，截至2024年06月30日，辉瑞收入总额281.62亿美元，同比减少10.57%；归母净利润31.56亿美元，同比减少59.9%。大事提醒：10月29日，辉瑞将于(美东)盘前披露2024财年三季报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/10/09223343853292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["SG9999002224.SGD","IE00BBT3K403.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU0170899867.USD","SG9999001176.SGD","LU1023059063.AUD","SG9999002232.USD","LU0306806265.USD","SG9999011175.SGD","BK4588","LU0289739699.SGD","LU0122379950.USD","BK4581","LU0868494617.USD","SG9999001176.USD","LU0321505439.SGD","BK4568","LU1894683264.USD","LU1066051498.USD","SGXZ57979304.SGD","BK4550","LU0306807586.USD","LU1894683348.USD","BK4534","LU1066053197.SGD","BK4592","SG9999003800.SGD","BK4533","IE00BLSP4452.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0234572021.USD","LU1057294990.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0321505868.SGD","LU0225284248.USD","SG9999013999.USD","LU0456855351.SGD","PFE","BK4585","BK4007","IE00BLSP4239.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pfizer.com","stockEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":-0.0169},{"period":"3month","weight":0.0083},{"period":"6month","weight":0.1276},{"period":"1year","weight":-0.1142},{"period":"ytd","weight":0.0129}],"compareEarnings":[{"period":"1week","weight":0.0115},{"period":"1month","weight":0.0454},{"period":"3month","weight":0.035},{"period":"6month","weight":0.1345},{"period":"1year","weight":0.3365},{"period":"ytd","weight":0.2194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"辉瑞公司于1942年6月2日根据特拉华州法律成立。公司是一家以研究为基础的全球性生物制药公司。公司运用科学和全球资源，通过发现、开发、制造和分销保健产品（包括创新药物和疫苗），为人们带来延长和显著改善其生活的疗法。公司在发达国家和新兴市场开展工作，致力于促进健康、预防、治疗和治愈这个时代最令人恐惧的疾病。公司与医疗保健提供商、政府和当地社区合作，支持并扩大在全球范围内获得可靠、负担得起的医疗保健服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.00126},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.007167},{"month":3,"riseRate":0.613636,"avgChangeRate":0.015985},{"month":4,"riseRate":0.6,"avgChangeRate":0.019475},{"month":5,"riseRate":0.511111,"avgChangeRate":0.008757},{"month":6,"riseRate":0.488889,"avgChangeRate":0.00215},{"month":7,"riseRate":0.488889,"avgChangeRate":0.01248},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.001198},{"month":9,"riseRate":0.444444,"avgChangeRate":0.003884},{"month":10,"riseRate":0.666667,"avgChangeRate":0.014717},{"month":11,"riseRate":0.704545,"avgChangeRate":0.030213},{"month":12,"riseRate":0.5,"avgChangeRate":0.0093}],"exchange":"NYSE","name":"辉瑞","nameEN":"Pfizer"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"辉瑞,PFE,辉瑞股票,辉瑞股票老虎,辉瑞股票老虎国际,辉瑞行情,辉瑞股票行情,辉瑞股价,辉瑞股市,辉瑞股票价格,辉瑞股票交易,辉瑞股票购买,辉瑞股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"辉瑞(PFE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供辉瑞(PFE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}